| Description | Sodium taurocholate (Taurocholate Sodium) hydrate is the main end product of cholesterol catabolism. During enterohepatic circulation, bile taurocholic acid is converted by the microorganisms to taurodeoxycholic acid and deoxycholic acid.[3] These are reabsorbed by the liver via a carrier-mediated process and converted by liver enzymes to taurocholic acid. |
| Synonyms | 牛黄胆酸钠(牛胆酸钠，牛胆酸钠盐，牛磺膽酸鈉，牛磺胆酸钠，牛磺胆酸钠盐，牛胆酸钠水合物，水合牛磺胆酸钠，牛胆酸钠(混合物)，牛黄胆酸钠(水合)，牛磺胆酸钠(标准品)), Taurocholate Sodium |
| molecular weight | 537.69 |
| Molecular formula | C26H44NO7S.Na |
| CAS | 145-42-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 60 mg/mL (111.59 mM) |
| References | 1. Khatun, Z., Nurunnabi, M., Cho, K., Byun, Y., Bae, Y., & Lee, Y. (2014). Oral absorption mechanism and anti-angiogenesis effect of taurocholic acid-linked heparin-docetaxel conjugates. Journal Of Controlled Release, 177, 64-73. doi: 10.1016/j.jconrel.2013.12.034 2. Mathavan, S., Mikov, M., Golocorbin-Kon, S., & Al-Salami, H. (2017). Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects. European Journal Of Pharmaceutical Sciences, 106, 1-9. doi: 10.12016/j.ejps.2017.05.041 |